IRIDIA, INC.
Semiconductor-based DNA synthesizer device using enzyme-catalyzed synthesis in nanopore reactors to synthesize long DNA oligonucleotides (2000+ base pairs)
- Sector
- Biotech
- Headquarters
- Carlsbad, CA
- Founded
- 2016
- Latest Form D
- $6M, Nov 2021
- Total capital
- $18.8M
- Federal grants
- $255K
- 1 award · 2022
- Rank in peer group#9 of 22
- Private capital raised
- $18.6M
- 5 Form D · last Nov 2021
- 59 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 14
- 19 pending · first 2019
- Rank in peer group#1 of 22
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of an Accurate, Long and Fast DNA Synthesis Device$255K
- Private capital raisedForm D · SEC · 5th filing$6M
- Private capital raisedForm D · SEC · 4th filing$7.6M
- Private capital raisedForm D · SEC · 3rd filing$2.5M
- Private capital raisedForm D · SEC · 2nd filing$2M
- Private capital raisedForm D · SEC · 1st filing$400K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 22 peers
Line = medianBiotech · Device
- Federal grants#9 · top 41%
- Granted patents#1 · top 5%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- PAUL P. PREDKIResearcherExecutive Officer, DirectorLinked by 11 patents · $255K in grants as PI
- Amy P. KruseDirectorNamed in SEC Form D filings
- CHRIS P. CAMARSHDirectorNamed in SEC Form D filings
- Gwen P RuffExecutive OfficerNamed in SEC Form D filings
- James P LintonDirectorNamed in SEC Form D filings
- JAY P. FLATLEYDirectorNamed in SEC Form D filings
Show all 10 people
- Murali P. PrahaladDirectorNamed in SEC Form D filings
- Paul P. YookDirectorNamed in SEC Form D filings
- Peter P LongoDirectorNamed in SEC Form D filings
- Steve P. BarnardDirectorNamed in SEC Form D filings
What it has protected
USPTO · 14 granted of 33- GrantedNovel Enzymes And Systems For Synthesizing DnaUSPTOUS 12,338,470
- PendingSystems And Methods For Writing Data Stored In A Polymer Using Inkjet DropletsUSPTOApplication 18444662
- GrantedSystems And Methods For Writing And Reading Data Stored In A PolymerUSPTOUS 11,923,004
Show all 33 patent records
- Novel Enzymes And Systems For Synthesizing DnaJun 24, 2025 · US 12,338,470Granted
- Systems And Methods For Writing Data Stored In A Polymer Using Inkjet DropletsSep 19, 2024 · Application 18444662Pending
- Systems And Methods For Writing And Reading Data Stored In A PolymerMar 5, 2024 · US 11,923,004Granted
- Systems And Methods For Writing And Reading Data Stored In A Polymer Using Nano-channelsDec 5, 2023 · US 11,837,302Granted
- Systems And Methods For Writing, Reading, And Controlling Data Stored In A PolymerOct 26, 2023 · Application 18152110Pending
- Systems And Methods For Writing, Reading, And Controlling Data Stored In A PolymerSep 7, 2023 · Application 18057650Pending
- Novel Enzymes And Systems For Synthesizing DnaMay 23, 2023 · US 11,655,465Granted
- Systems And Methods For Writing And Reading Data Stored In A PolymerMar 7, 2023 · US 11,600,324Granted
- Systems And Methods For Writing, Reading, And Controlling Data Stored In A PolymerJan 10, 2023 · US 11,549,140Granted
- Systems And Methods For Writing And Reading Data Stored In A Polymer Using Nano-channelsJan 3, 2023 · US 11,545,213Granted
- Methods of Synthesizing DNANov 22, 2022 · US 11,505,825Granted
- Systems And Methods For Writing And Reading Data Stored In A PolymerOct 19, 2021 · US 11,152,061Granted
- Systems And Methods For Writing, Reading, And Controlling Data Stored In A PolymerMay 4, 2021 · US 10,995,373Granted
- Methods, Compositions, And Devices For Information StorageDec 8, 2020 · US 10,859,562Granted
- Methods, Compositions, And Devices For Information StorageJul 14, 2020 · US 10,714,178Granted
- Systems And Methods For Writing, Reading, And Controlling Data Stored In A PolymerMay 5, 2020 · US 10,640,822Granted
- Methods, Compositions, And Devices For Information StorageOct 8, 2019 · US 10,438,662Granted
- Counterfeit Protection Using DnaApplication 19519051Pending
- Systems And Methods For Writing Data Stored In A Polymer Using LightApplication 63721368Pending
- Counterfeit Protection Using DnaApplication PCTUS2024046372Pending
- Systems And Methods For Writing Data Stored In A Polymer Using Inkjet DropletsApplication PCTUS2024016324Pending
- Counterfeit Protection Using DnaApplication 63623085Pending
- Counterfeit Protection Using DnaApplication 63582199Pending
- Systems And Methods For Writing Data Stored In A Polymer Using Inkjet DropletsApplication 63485832Pending
- Systems And Methods For Writing And Reading Data Stored In A Polymer Using Nano-channelsApplication 63063066Pending
- Improved Systems And Methods For Writing And Reading Data Stored In A PolymerApplication PCTUS2019050021Pending
- Systems And Methods For Multi-bit Writing And Reading Data Stored In A PolymerApplication 62842373Pending
- Systems And Methods For Writing, Reading, And Controlling Data Stored In A PolymerApplication PCTUS2019030463Pending
- Novel Enzymes And Systems For Synthesizing DnaApplication 62842333Pending
- Systems And Methods For Writing, Reading, And Controlling Data Stored In A PolymerApplication 62728656Pending
- Methods, Compositions, And Devices For Information StorageApplication PCTUS2017059100Pending
- Methods, Compositions, And Devices For Information StorageApplication PCTUS2017020044Pending
- Systems And Methods For Writing Data Stored In A Polymer Using LightApplication PCTUS2025055834Pending
Related companies, and why
- Veltion Therapeutics LLCSimilar federal contract value in Biotech · null in contracts
- Corridor Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Processa Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Bluejay TherapeuticsSimilar federal contract value in Biotech · null in contracts
- STINGINN, LLCSimilar federal contract value in Biotech · null in contracts
- NOVICI BIOTECH, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .